The Pharma Forum returns – this time to our newly renovated London office on 4 February 2026. At this event, will explore the latest developments in European patent litigation and pharmaceutical regulation.
Our panel of international experts will:
- decode recent rulings and their practical impact on cross-border litigation
- review key UPC case law trends and how they align, or diverge, from national and EPO approaches on substantiative points of law
- explore the EU’s pharma reform package, one of the most ambitious regulatory overhauls for medicinal products in decades.
| 14:00-14:30 |
Welcome and registration |
| 14:30-15:40 |
Cross-border jurisdiction in patent cases: what to do when the boundaries keep changing? With Amanda Ebbutt, Jules Fabre, Bas Berghuis and Gisbert Hohagen
|
| 15:40-16:00 |
UPC case law review: key trends and pivotal decisions (part one) with Matt Royle |
| 16:00-16:20 |
Break |
| 16:20-16:40 |
UPC case law review: key trends and pivotal decisions divergences (part two) with Chris Thornham and Nora Wessendorf
|
| 16:40-17:30 |
EU pharma reform: at the finish line? With Andrew Payne, Eoin Martyn and Daisy Termeulen
|
| 17:30-18:30 |
Networking drinks and canapes |
| 18:30 |
Event close |
in Präsenz
Online
